Headquarters Hong Kong | Founded 2004 | |
 | ||
Stock price 2005 (HKG) HK$ 2.87 +0.04 (+1.41%)17 Mar, 4:00 PM GMT+8 - Disclaimer Subsidiaries Shenzhen Lijun Pharmaceutical Co., Ltd. | ||
Lijun International Pharmaceutical (Holding) Co., Limited (simplified Chinese: 利君国际医药(控股)有限公司; traditional Chinese: 利君國際醫藥(控股)有限公司) (SEHK: 2005) is a Wanchai, Hong Kong-based investment holding company with two pharmaceutical business segments:
Contents
Business segments
The Group was listed on Hong Kong Stock Exchange in December 2005 (stock code: 2005).
The Group is engaged in the research, development, manufacturing and selling of a wide range of finished medicines and bulk pharmaceutical products to hospitals and distributors, including antibiotics, intravenous infusion solution, non-antibiotics finished products, bulk pharmaceuticals and health care product.
Subsidiaries
The Company’s subsidiaries include:
The Company is the largest domestic manufacturer of macrolide antibiotics, with a leading position for its intravenous infusion solution products in high-end hospital market.
Facing more merger and acquisition opportunities from medical reform in China, the Group is positioned for continuous mergers and acquisitions to promote its growth.